Catalyst Pharmaceuticals, Inc.

Cetera Investment Advisers CPRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

56,036

Value ($000)

1,308

Weight

0.0%

2020 Q4 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,308	0.0%	56,036	12/31/2025
2025 Q3	11/14/2025	1,034	0.0%	52,479	9/30/2025
2025 Q2	8/8/2025	1,188	0.0%	54,728	6/30/2025
2025 Q1	5/6/2025	1,411	0.0%	58,180	3/31/2025
2024 Q4	2/14/2025	900	0.0%	43,114	12/31/2024
2024 Q3	11/13/2024	634	0.0%	31,893	9/30/2024
2024 Q2	8/22/2024	526	0.0%	33,946	6/30/2024
2024 Q1	5/24/2024	458	0.0%	28,749	3/31/2024
2023 Q4	2/13/2024	367	0.0%	21,816	12/31/2023
2023 Q3	11/14/2023	179	0.0%	15,283	9/30/2023
2023 Q2	8/10/2023	205	0.0%	15,223	6/30/2023
2023 Q1	5/15/2023	234	0.0%	14,127	3/31/2023
2022 Q4	2/14/2023	242	0.0%	13,000	12/31/2022
2022 Q2	8/11/2022	121	0.0%	17,275	6/30/2022
2022 Q1	5/13/2022	143	0.0%	17,275	3/31/2022
2021 Q4	2/14/2022	120	0.0%	17,652	12/31/2021
2021 Q3	11/16/2021	94	0.0%	17,652	9/30/2021
2021 Q2	8/13/2021	101	0.0%	17,652	6/30/2021
2021 Q1	5/17/2021	79	0.0%	17,109	3/31/2021
2020 Q4	2/17/2021	57	0.0%	17,000	12/31/2020